A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With Hypercholesterolemia
Clinical trial NCT01779453 · COMPLETED
Trial details
- NCT number
- NCT01779453
- Sponsor
- Esperion Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2013-08-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.